Physician profile
Devan R Walker
NPI 1487223699
$665.85
in general payments reported to CMS, 2019-2025
18 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $152 · 2023: $131 · 2024: $106 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $147.71 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $99.46 | 2023-2025 | Verquvo |
| Paratek Pharmaceuticals, INC. | $72.42 | 2022-2023 | Nuzyra |
| Astrazeneca Pharmaceuticals Lp | $48.50 | 2022-2025 | Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $47.48 | 2022-2025 | |
| Lilly USA, LLC | $38.66 | 2021-2025 | Mounjaro |
| Inogen, INC. | $23.71 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Lexicon Pharmaceuticals, INC. | $22.83 | 2024 | Inpefa |
| Glaxosmithkline, LLC. | $21.86 | 2023 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $19.93 | 2025 | |
| Pfizer INC. | $18.75 | 2025 | |
| Exact Sciences Corporation | $17.76 | 2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $15.59 | 2022 | |
| Axsome Therapeutics, INC. | $15.19 | 2025 | Auvelity |
| Evoke Pharma, INC. | $14.90 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.91 | 2022 | |
| Xeris Pharmaceuticals, INC. | $13.63 | 2024 | Gvoke Hypopen |
| Kowa Pharmaceuticals America, INC. | $13.56 | 2023 | Livalo, Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devan Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.